Efficacy and Safety of Sanggua Tablets in the Treatment of Patients With Impaired Glucose Tolerance and Mild Type 2 Diabetes
Clinical trial NCT06964620 · RECRUITING
Trial details
- NCT number
- NCT06964620
- Sponsor
- Tongji Hospital
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-22
- Primary completion
- 2027-11-24
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.